Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Breathe Deeply: Glaxo May Face Generic Advair Sooner Than Expected

11:41 EDT 10 Sep 2013 | Pharmalot

In a setback to GlaxoSmithKline, the FDA has issued a draft guidance that indicates the drugmaker may face generic competition for its best-selling Advair medication for asthma and chronic obstructive pulmonary disorder sooner than s...

Original Article: Breathe Deeply: Glaxo May Face Generic Advair Sooner Than Expected

NEXT ARTICLE

More From BioPortfolio on "Breathe Deeply: Glaxo May Face Generic Advair Sooner Than Expected"

Search BioPortfolio:
Advertisement

Relevant Topic

The Top 100 Pharmaceutical Companies
Latest News Clinical Trials Research Drugs Reports Corporate
Top 100 Pharmaceutical Companies 2012 (SCRIP 100 - http://www.scrip100.com/scrip100.html) Rank (2011 in Brackets) Company SEARCH FOR COMPANY IN BIOPORTFOLIO'S BIOCORPORATE DATABASE 2012 pharma sales...

Advertisement

Searches Linking to this Story